Foamix Pharmaceuticals uses 8 technology products and services including Drupal, Google Font API, jQuery, and more. Explore Foamix Pharmaceuticals's tech stack below.
| Foamix Pharmaceuticals Email Formats | Percentage |
| First.Last@foamix.com | 45% |
| Last@foamix.com | 5% |
| First.Last@foamix.com | 45% |
| Last@foamix.com | 5% |
Pharmaceutical ManufacturingIsrael51-200 Employees
Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
Company Overview
Funding & FinancialsFoamix Pharmaceuticals has raised a total of $64M of funding over 4 rounds. Their latest funding round was raised on Jul 30, 2019 in the amount of $64M.
Foamix Pharmaceuticals's revenue is in the range of $10M$50M
Funding & FinancialsFoamix Pharmaceuticals has raised a total of $64M of funding over 4 rounds. Their latest funding round was raised on Jul 30, 2019 in the amount of $64M.
Foamix Pharmaceuticals's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com